My point in initiating the post Rem-L needed NOW was the notion that if Rem-L was approved and available then medical resources could be utilized by the general populace in need care instead rather than just the unvaccinated who are currently monopolizing those resources. Rem-L could be a partial solution to the current dilemma by diminishing the need and duration of intensive care. I don't know if Australian hospitals have reached the crises point that hospitals in the US have reached, but to quote another "it is not if, but when".
Some have questioned whether reliance on the NY Times should be afforded the same deference as a medical journal in reporting how the unvaccinated are skewing care afforded to the unvaccinated for their self-inflicted and avoidable injury. But this isn't really a medical
controversy, its citing facts and the reporting of those facts. It is a real problem that is afoot and it is impacting lives. Choices will necessarily have to be made, but Rem-l could relieve some of that burden. See the link to a Washington Post OpEd by an attorney/physician.
https://wapo.st/3ucZjaf
- Forums
- ASX - By Stock
- MSB
- Rem-L needed Yesterday
Rem-L needed Yesterday
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.0¢ |
Change
-0.045(4.52%) |
Mkt cap ! $1.084B |
Open | High | Low | Value | Volume |
$1.00 | $1.01 | 94.5¢ | $2.669M | 2.769M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2053 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.5¢ | 13191 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2053 | 0.950 |
5 | 69192 | 0.945 |
16 | 152239 | 0.940 |
10 | 194253 | 0.935 |
9 | 112676 | 0.930 |
Price($) | Vol. | No. |
---|---|---|
0.955 | 13191 | 2 |
0.960 | 60726 | 4 |
0.965 | 33726 | 1 |
0.970 | 53885 | 3 |
0.975 | 54219 | 6 |
Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online